A fault-tolerant quantum computer can execute a practically useful quantum algorithm beyond classical simulation.
Verification position derived from the record’s assessments; dates show when Faultline first recorded each stage.
Causal mechanisms recorded for this claim. The State Warrant above remains the authoritative current assessment.
Classical algorithm improvement rate. The claim requires execution beyond classical simulation. Classical quantum chemistry and simulation methods continue to improve. For each proposed quantum advantage problem, the relevant comparison is against the best current classical method — which is itself a moving target. Tensor network methods, DMRG, and ML-augmented classical simulation have already classically solved some problems previously proposed as quantum advantage targets. The resistance mechanism is the same race dynamic as FR-QE-0005 RM-002, but operating on a nearer timescale and on problem classes where the race is currently active. The quantum side must advance faster than the classical side on the specific problem instances where advantage is claimed.
No agreed quantum advantage target problem. The claim requires a practically useful algorithm beyond classical simulation, but no consensus exists on which specific problem instance will first satisfy both criteria simultaneously. The quantum chemistry community has proposed FeMoco (nitrogen fixation catalyst), ruthenium-based catalysts, and vibrational spectra of small molecules as candidate first-advantage problems — but as classical methods improve, each candidate may become classically tractable before quantum hardware reaches the required scale. The bottleneck is that the first claim satisfaction event requires landing on a specific problem instance where quantum hardware reaches the required scale before classical methods solve it. The problem instance cannot be identified in advance with certainty.
First 1000-logical-qubit fault-tolerant chemistry demonstration. Resource estimation identifies approximately 1000–4000 logical qubits as sufficient for the first practically useful fault-tolerant quantum chemistry calculations. If a system of this scale is demonstrated with below-threshold error rates and executes a quantum chemistry calculation on a problem instance not tractable classically, the claim would be satisfied. The attractor is more tightly defined and closer in engineering terms than FR-QE-0005's attractor, making this record the most near-term application claim in PROG-QE. Several hardware roadmaps (IBM, Google, Microsoft) project this scale within five to ten years under optimistic assumptions.
Historical narrative recorded for this claim. It does not override the current State Warrant.
Questions retained in this record. The current State Warrant may have narrowed or reframed earlier questions.
Which specific molecular or physical system will provide the first unambiguous fault-tolerant quantum advantage? The absence of an agreed target problem (BN-001) means the claim may be satisfied on a problem not currently anticipated. Whether the first advantage demonstration will be accepted as "practically useful" by the broader scientific community depends on which problem it solves.
Raised 2024-01-15Does the PROG-QE diagnosis — technically coherent but temporally displaced — create investment sustainability risk? The programme requires years to decades of continued investment before applications are reachable. If investment cycles shorten before the applications arrive, the substrate may stop advancing before the claim is satisfied. This is an institutional question rather than a technical one, but it is now the programme's structural tension.
Raised 2024-01-15All three programme diagnoses are now established. Is there a meta-observation available about what kinds of programmes generate which kinds of diagnoses? PROG-AI: surface/depth inversion (advancing capabilities, contested foundations). PROG-AM: collapse dynamic (competitive pressure, premature announcement). PROG-QE: temporal displacement (coherent foundations, distant applications). Are these diagnosis types a property of the domains, or of the specific claim configurations the Observatory selected?
Raised 2024-01-15| Mutation | Date | Field | Prior value | Current value |
|---|---|---|---|---|
| M-011 | 2026-09-06 | description_restored | Legacy ingestion cutoffs: mechanisms:RM-001, mechanisms:BN-001, mechanisms:AT-001 | Source-restored complete descriptions |
| M-010 | 2026-08-17 | assessment_issued | AS-001 | AS-002 |
| M-009 | 2026-07-14 | instance_appended | — | IN-006 |
| M-008 | 2026-07-08 | reference_corrected | — | REFERENCE-CORRECTED |
| M-007 | 2026-07-08 | realization_note_added | — | REN-001 |
| M-006 | 2024-01-15 | programme_panel_added | — | PROGRAMME-PANEL-ADDED |
| M-005 | 2024-01-15 | null_condition_failed | — | NULL-CONDITION-FAILED |
| M-004 | 2024-01-15 | mechanisms_recorded | — | MECHANISMS-RECORDED |
| M-003 | 2024-01-15 | assessment_issued | — | ASSESSMENT-ISSUED |
| M-002 | 2024-01-15 | instances_logged | — | INSTANCES-LOGGED |
| M-001 | 2024-01-15 | record_created | — | RECORD-CREATED |